Polymer-based non-viral gene delivery as a concept for the treatment of cancer

Anwer, 2000, Targeted gene delivery: a two-pronged approach, Crit Rev Ther Drug Carrier Syst, 17, 377, 10.1615/CritRevTherDrugCarrierSyst.v17.i4.30 Biber, 2002, Intracellular router and transcriptional competence of polyethylenimine-DNA complexes, J Control Release, 82, 441, 10.1016/S0168-3659(02)00129-3 Bielawska, 2001, L-proline analogues of anthraquinone-2-carboxylic acid: cytotoxic activity in breast cancer MCF-7 cells and inhibitory activity against topoisomerase I and II, Pol J Pharmacol, 53, 283 Bielawski, 2001, DNA-binding properties and cytotoxicity of extended aromatic bisamidines in breast cancer MCF-7 cells, Pol J Pharmacol, 53, 143 Bielawski, 2004, Inhibition of DNA topoisomerase I and II, and growth inhibition of MDA-MB-231 human breast cancer cells by bisbenzimidazole derivatives with alkylating moiety, Pol J Pharmacol, 56, 373 Boeckle, 2006, Melittin analogs with high lytic activity at endosomal pH enhance transfection with purified targeted PEI polyplexes, J Control Release, 112, 240, 10.1016/j.jconrel.2006.02.002 Chollet, 2002, Side-effects of a systemic injection of linear polyethylenimine-DNA complexes, J Gene Med, 4, 84, 10.1002/jgm.237 Demeneix, 2004, Towards multifunctional synthetic vectors, Curr Gene Ther, 4, 445, 10.2174/1566523043345940 Heidel, 2007, Potent siRNA inhibitors of ribonucleotide reductase subunit RRM2 reduce cell proliferation in vitro and in vivo, Clin Cancer Res, 13, 2207, 10.1158/1078-0432.CCR-06-2218 Heidel, 2007, Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA, Proc. Natl. Acad. Sci. USA, 104, 5715, 10.1073/pnas.0701458104 Kaufmann, 1993, Cell cycle control, DNA repair and initiation of carcinogenesis. FASEB J, 7, 1188 Kelter, 2007, Role of transferrin receptor and the ABC transporters ABCB6 and ABCB7 for resistance and differentiation of tumor cells towards artesunate., PLoS ONE, 2, 10.1371/journal.pone.0000798 e798 Kichler, 2004, Gene transfer with modified polyethylene mines, J Gene Med, 6, S3, 10.1002/jgm.507 Kichler, 2001, Polyethylenimine-mediated gene delivery: a mechanistic study, J Gene Med, 3, 135, 10.1002/jgm.173 Kircheis, 2001, Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application, Gene Ther, 8, 28, 10.1038/sj.gt.3301351 Ko, 2001, Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice, Mol Ther, 4, 313, 10.1006/mthe.2001.0459 Kursa, 2003, Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer, Bioconjug Chem, 14, 222, 10.1021/bc0256087 Kwoh, 1999, Stabilization of poly-L-lysine/DNA polyplexes for in vivo gene delivery to the liver, Biochim Biophys Acta, 1444, 171, 10.1016/S0167-4781(98)00274-7 Lim, 1999, A self-destroying polycationic polymer: biodegradable poly(4-hydroxy-L-proline ester), J Am Chem Soc, 121, 5633, 10.1021/ja984012k Lim, 2000, Biodegradable polyester, poly[α-(4-aminobutyl)-L-glycolic acid], as a non-toxic gene carrier, Pharm Res, 17, 811, 10.1023/A:1007552007765 Marshall, 1999, Gene therapy death prompts review of adenovirus vector, Science, 286, 2244, 10.1126/science.286.5448.2244 McKenzie, 2000, A potent new class of reductively activated peptide gene delivery agents, J Biol Chem, 275, 9970, 10.1074/jbc.275.14.9970 Merdan, 2002, Intracellular processing of poly(ethylene imine)/ribozyme complexes can be observed in living cells by using confocal laser scanning microscopy and inhibitor experiments, PharmRes, 19, 140 Mintzer, 2009, Nonviral vectors for gene delivery, Chem Rev, 109, 259, 10.1021/cr800409e Mukherjee, 1997, Endocytosis Physiol Rev, 77, 759, 10.1152/physrev.1997.77.3.759 Neu, 2007, Bioreversibly crosslinked polyplexes of PEI and high molecular weight PEG show extended circulation times in vivo, J Control Release, 124, 69, 10.1016/j.jconrel.2007.08.009 Neu, 2007, Crosslinked nanocarriers based upon poly(ethylene imine) for systemic plasmid delivery: in vitro characterization and in vivo studies in mice, J Control Release, 118, 370, 10.1016/j.jconrel.2007.01.007 Neu, 2006, Stabilized nanocarriers for plasmids based upon cross-linked Poly(ethylene imine), Biomacromolecules, 7, 3428, 10.1021/bm060788z Ogris, 1999, PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery, Gene Ther, 6, 595, 10.1038/sj.gt.3300900 Ogris, 2002, Targeting tumors with non-viral gene delivery systems, Drug Discov Today, 7, 479, 10.1016/S1359-6446(02)02243-2 Ohana, 2004, Regulatory sequences of the H19 gene in DNA based therapy of bladder cancer, Gene Ther Mol Biol, 8, 181 Oupický, 2001, Triggered intracellular activation of disulfide crosslinked polyelectrolyte gene delivery complexes with extended systemic circulation in vivo, Gene Ther, 8, 713, 10.1038/sj.gt.3301446 Parada-Turska, 2007, Antiproliferative activity of parthenolide against three human cancer cell lines and human umbilical vein endothelial cells, Pharmacol Rep, 59, 233 Parker, 2005, Enhanced gene transfer activity of peptide-targeted gene-delivery vectors, J Drug Target, 13, 39, 10.1080/10611860400020449 Plank, 1992, Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand, Bioconjug Chem, 3, 533, 10.1021/bc00018a012 Russ, 2008, Oligoethylenimine-grafted polypropylenimine dendrimers as biodegradable and biocompatible synthetic vectors for gene delivery, J Control Release, 132, 131, 10.1016/j.jconrel.2008.09.003 Russ, 2007, Cell and tissue targeting ofnucleic acids for cancer gene therapy, Pharm Res, 24, 1047, 10.1007/s11095-006-9233-9 Szybalska, 1962, Genetics of human cess line. IV. DNA-mediated heritable transformation of a biochemical trait, Proc Natl Acad Sci USA, 48, 2026, 10.1073/pnas.48.12.2026 Wagner, 2004, Strategies to improve DNA polyplexes for in vivo gene transfer: will “artificial viruses” be the answer?, Pharm Res, 21, 8, 10.1023/B:PHAM.0000012146.04068.56 Wagner, 1990, Transferrin-polycation conjugates as carriers for DNA uptake into cells, Proc Natl Acad Sci USA, 87, 3410, 10.1073/pnas.87.9.3410 Wesierska-Gądek, 2004, Cell cycle arrest induced in human breast cancer cells by cyclin-dependent kinase inhibitors: a comparison of the effects exerted by roscovitine and olomoucine, Pol J Pharmacol, 56, 635 Wiela-Hojeńska, 2007, N-acetyl-beta-D-glucosaminidase activity in patients with ovarian cancer and testicular embryonal carcinomas treated with cisplatin, Pharmacol Rep, 59, 192 Wojtowicz-Praga, 1997, Reversal of tumor-induced immuno-suppression: a new approach to cancer therapy, J Immu-nother, 20, 165, 10.1097/00002371-199705000-00001 Wolfert, 1999, Polyelectrolyte vectors for gene delivery: influence of cationic polymer on biophysical properties of complexes formed with DNA, Bioconjug Chem, 10, 993, 10.1021/bc990025r Wu, 1989, Targeting genes: delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo, J Biol Chem, 264, 16985, 10.1016/S0021-9258(18)71447-6 Wu, 1987, Receptor-mediated in vitro gene transformation by a soluble DNA carrier system, J Biol Chem, 262, 4429, 10.1016/S0021-9258(18)61209-8 Yamamoto, 2009, Current prospects for mRNA gene delivery, Eur J Pharm Biopharm, 71, 484, 10.1016/j.ejpb.2008.09.016 Zhang, 2008, A biodegradable, immunoprotective, dual nanoporous capsule for cellbased therapies, Biomaterials, 29, 4253, 10.1016/j.biomaterials.2008.07.032